Screener
ClearPoint Neuro CLPT Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Other (expense) income, net | (35) | 4 |
| Interest income | 351 | 151 |
| Interest expense | (1,382) | — |
| Net loss before income taxes | (9,544) | (6,008) |
| Income tax expense | 8 | 18 |
| Net loss | $(9,552) | $(6,026) |
| Net loss per share attributable to common stockholders: | ||
| Basic and diluted | $(0.32) | $(0.22) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's pre-tax income?
- ClearPoint Neuro (CLPT) reported pre-tax income of -$9.54M in Q1 2026.
- How has ClearPoint Neuro's pre-tax income changed year-over-year?
- ClearPoint Neuro's pre-tax income decreased by 58.9% year-over-year, from -$6.01M to -$9.54M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about ClearPoint Neuro's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude